210
Views
7
CrossRef citations to date
0
Altmetric
Review Articles

Isolated brainstem involvement in posterior reversible encephalopathy syndrome: a case report and review of the literature

, , &
Pages 808-813 | Received 10 Jul 2018, Accepted 10 Dec 2018, Published online: 17 Feb 2019

References

  • Hinchey J, Chaves C, Appignani B, et al. A reversible posterior leukoencephalopathy syndrome. N Engl J Med. 1996;334:494–500.
  • Fugate JE, Claassen DO, Cloft HJ, et al. Posterior reversible encephalopathy syndrome: associated clinical and radiologic findings. Mayo Clin Proc. 2010;85:427–432.
  • Chang GY, Keane JR. Hypertensive brainstem encephalopathy: three cases presenting with severe brainstem edema. Neurology. 1999;53:652–654.
  • Chang GY, Keane JR. Hypertensive brain stem encephalopathy. AJNR Am J Neuroradiol. 2000;21:1366
  • Drees C, Alkotob L, Hall PM, et al. Reversible pontine edema in hypertension. Neurology. 2001;56:659
  • Thambisetty M, Biousse V, Newman NJ. Hypertensive brainstem encephalopathy: clinical and radiographic features. J Neurol Sci. 2003;208:93–99.
  • Gamanagatti S, Subramanian S. Hypertensive encephalopathy: isolated pons involvement mimicking central pontine myelinolysis. Korean J Radiol. 2006;7:218–219.
  • Uchino M, Haga D, Nomoto J, et al. Brainstem involvement in hypertensive encephalopathy: a report of two cases and literature review. Eur Neurol. 2007;57:223–226.
  • McCarron MO, McKinstry CS. Vanishing brainstem edema. J Stroke Cerebrovasc Dis. 2008;17:156–157.
  • El Maalouf G, Mitry E, Lacout A, et al. Isolated brainstem involvement in posterior reversible leukoencephalopathy induced by bevacizumab. J Neurol. 2008;255:295–296.
  • Shintani S, Hino T, Ishihara S, et al. Reversible brainstem hypertensive encephalopathy (RBHE): clinicoradiologic dissociation. Clin Neurol Neurosurg. 2008;110:1047–1053.
  • Chen TY, Lee HJ, Wu TC, et al. MR imaging findings of medulla oblongata involvement in posterior reversible encephalopathy syndrome secondary to hypertension. AJNR Am J Neuroradiol. 2009;30:755–757.
  • Medici E, Arabi S, Sebastianelli M, et al. A case of hypertensive encephalopathy with prominent brainstem presentation. Neurol Sci. 2009;30:133–135.
  • Fitzgerald RT, Osorio J, Panigrahy A, et al. Isolated leptomeningeal enhancement in tacrolimus-associated posterior reversible encephalopathy syndrome. Pediatr Neurol. 2013;48:76–78.
  • Liang H, Li D, Xu Z, et al. Isolated pons variant of posterior reversible encephalopathy syndrome complicated with ischemic stroke in a young patient. Neurol Sci. 2013;34:585–587.
  • Gao B, Liang H, Liu FL, et al. Isolated pons involvement in posterior reversible encephalopathy syndrome in a patient with chronic renal insufficiency: case report and literature review. Clin Neuroradiol. 2012;22:341–344.
  • Osman Y, Imam YZ, Salem K, et al. Isolated brainstem involvement in a patient with hypertensive encephalopathy. Case Rep Neurol Med. 2013;2013:7. doi: 10.1155/2013/540947.
  • Yafour N, Krim A, Bouhass R, et al. Cyclosporine-related brainstem atypical posterior reversible leukoencephalopathy syndrome following hematopoietic stem cell transplant. Hematol Oncol Stem Cell Ther. 2016;9:36–38.
  • Liao PY, Lee CC, Chen CY. Hypertensive brain stem encephalopathy. Am J Emerg Med. 2015;33:e5–e7.
  • Ho TH, Kao HW, Chen SJ, et al. Hypertensive brainstem encephalopathy mimicking central pontine myelinolysis: a potential pitfall. Am J Emerg Med. 2016;34:e5–e7.
  • Tang KH. Oxaliplatin-induced posterior reversible encephalopathy syndrome with isolated involvement of pons. J Can Res Ther. 2015;11:1022.
  • Ho TH, Tsai CL, Hsu YD, et al. Posterior reversible encephalopathy syndrome mimicking brainstem infarction: a dilemma. Acta Neurol Taiwan. 2016;25:56–59.
  • Ferrara M, Di Viesti P, Inchingolo V, et al. Isolated pons involvement in posterior reversible encephalopathy syndrome: case report and review of the literature. eNeurologicalSci. 2017;6:51–54.
  • Jia LJ, Qu ZZ, Zhang XQ. Uremic encephalopathy with isolated brainstem involvement revealed by magnetic resonance image: a case report. BMC Neurol. 2017;17:154.
  • Hadjipanayis A, Efstathiou E, Theophilou L, et al. Reversible brain lesion following growth hormone replacement therapy in an adolescent. BMJ Case Rep. 2017;2017.
  • Ni J, Zhou LX, Hao HL, et al. The clinical and radiological spectrum of posterior reversible encephalopathy syndrome: a retrospective series of 24 patients. J Neuroimaging. 2011;21:219–224.
  • Yoon SD, Cho BM, Oh SM, et al. Clinical and radiological spectrum of posterior reversible encephalopathy syndrome. J Cerebrovasc Endovasc Neurosurg. 2013;15:206–213.
  • Rabinstein AA, Mandrekar J, Merrell R, et al. Blood pressure fluctuations in posterior reversible encephalopathy syndrome. J Stroke Cerebrovasc Dis. 2012;21:254–258.
  • Bartynski WS, Boardman JF. Distinct imaging patterns and lesion distribution in posterior reversible encephalopathy syndrome. AJNR Am J Neuroradiol. 2007;28:1320–1327.
  • Magaña SM, Matiello M, Pittock SJ, et al. Posterior reversible encephalopathy syndrome in neuromyelitis optica spectrum disorders. Neurology. 2009;72:712–717.
  • Bartynski WS. Posterior reversible encephalopathy syndrome, part 2: controversies surrounding pathophysiology of vasogenic edema. AJNR Am J Neuroradiol. 2008;29:1043–1049.
  • Schwartz RB, Feske SK, Polak JF, et al. Preeclampsia-eclampsia: clinical and neuroradiographic correlates and insights into the pathogenesis of hypertensive encephalopathy. Radiology. 2000;217:371–376.
  • Staykov D, Schwab S. Posterior reversible encephalopathy syndrome. J Intensive Care Med. 2012;27:11–24.
  • Biousse V, Newman NJ, Chang GY. Brainstem involvement in hypertensive encephalopathy: clinical and radiological findings. Neurology. 2004;63:1759–1760.
  • Moon SN, Jeon SJ, Choi SS, et al. Can clinical and MRI findings predict the prognosis of variant and classical type of posterior reversible encephalopathy syndrome (PRES)? Acta Radiol. 2013;54:1182–1190.
  • Jung SM, Moon SJ, Kwok SK, et al. Posterior reversible encephalopathy syndrome in Korean patients with systemic lupus erythematosus: risk factors and clinical outcome. Lupus. 2013;22:885–891.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.